Skip to main content

Table 4 Comparative studies on incidence of PEI after pancreatic resection

From: Pancreatic exocrine insufficiency after pancreatic resection: a systematic review

Study

Prospective or retrospective

Sample size

Surgical procedures

Indication for surgical procedure

Test used

Reported PEI incidence

Reported Sensitivity -Specificity

Significant differences

Benini 2019 [23]

Retrospective

34

PD 100%

DP 0%

Malignant lesions, NET, benign lesions, other

FE-1 test

Faecal fat

84%

77%

NA

NA

Halloran 2011 [25]

Prospective

40

PD 93%

DP 7%

Malignant lesions

FE-1 test

Faecal fat

83%

55%

Sens. 91%

Specif. 35%

Accuracy 70%

for FE-1

(CFA > 93% as reference standard)

NA

Lemaire 2000 [32]

Prospective

19

PD 89%

DP 0%

Malignant lesion (pancreatic cancer excluded), benign lesions

FE-1 test

Faecal fat

100%

94%

Sens. 91%

Specif. 35%

for FE-1

(FFE > 6 g as reference standard)

NA

Muniz 2014 [35]

Retrospective

15

PD 100%

DP 0%

NA

FE-1 test

13 C breath test

47%

47%

NA

NA

Nakamura 2009 [36]

Retrospective

95

PD 54%

DP 14%

Malignant lesions, NET, benign lesions, other

FE-1 test

13 C breath test

62%

88%

Sens. 90%

Specif. 52%

Accuracy 62%

for FE-1

Sens. 69%

Specif. 93%

Accuracy 88%

for 13 C breath test

(steatorrhea as reference standard)

NA

Powell-Brett 2024 [42]

Prospective

26

PD 100%

DP 0%

Malignant lesions, NET, benign lesions

FE-1 test

13 C breath test

88%

60%

NA

NA

  1. FE-1: Faecal elastase 1; 13 C: 13 C-labelled mixed triglyceride breath test; PD: pancreatoduodenectomy; DP: distal pancreatectomy; NET: Neuroendocrine tumours; CFA: coefficient of fat absorption; FFE: faecal fat excretion; NA: Not available